Lawsuits Challenging Medicare Drug Negotiation Program Mount
- June 23, 2023
The Pharmaceutical Research and Manufacturers of America (PhRMA) and Bristol Myers Squibb Co. (BMS) have each filed lawsuits seeking to block the new Medicare drug price negotiation program.
ARTICLE TAGS
You must be logged in to access this content.